FDA — authorised 11 June 1996
- Application: NDA020666
- Marketing authorisation holder: IMPAX LABS INC
- Local brand name: ALBENZA
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Albendazole on Day 1 on 11 June 1996
Yes. FDA authorised it on 11 June 1996.
IMPAX LABS INC holds the US marketing authorisation.